Matias, M
The antioxidant role of non-mitochondrial CoQ10: mystery solved
Subcutaneous is the most common for research purposes, typically injected into fatty tissue (e.g., abdomen or thigh)
Many patients think they want a GLP-1, when what they really want is sustainable weight loss and better health
Medical detox and treatment programs focus on: Stabilizing the body safely Managing withdrawal symptoms with oversight Supporting sleep, nutrition, and mental health Medications like: Buprenorphine Methadone Naltrexone Have strong evidence showing they: Reduce cravings Lower overdose risk Improve long-term outcomes Sleep and stress, which DSIP targets, are also addressed through: Structured care Therapy Medication when appropriate Routine and stabilization A Better Way to Look at It DSIP is interesting from a research perspective
This is a common concern for patients considering or taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda, Victoza) for type 2 diabetes or weight management
